Evolution of GPP

GPP has grown over time, from defining the criteria for sponsor-based publications to bringing more credibility and openness to non-academic publications. It shows the main features of all three GPP models that have released so far.

GPP

  • Standards for publications arising from Phase H and Phase III clinical trials
  • Includes company-sponsored review articles and secondary papers
  • Publications from independent investigators studies not included

GPP2

  • More authority to authors in terms of data sharing and knowledge of sponsor’s publication policy
  • The distinction between authorship, contributorship, and acknowledgements
  • Role of Professional medical writers.

GPP3

  • Public posting of clinical protocols and results
  • Protocol and results to  published for all clinical trials
  • Timing of publications
  • Publications should follow applicable guidelines: FDA 2007,1CMJE. EQUATOR
  • Steps to avoid duplicate publications (ethical guidelines to avoid redundancy) and plagiarism

One of the key salient features of the GPP3 is “Reporting, and publication processes should follow Gpp3 reporting guidelines and applicable laws, such as those of the International Committee of Medical Journal Editors (ICMJE recommendations.” Along with recommendations “we recommend,” the guideline is now more assertive about what investigators, writers, and companies “should,” or sometimes even “must,” do. In this way, the guideline, in conjunction with other publication guidelines, will improve the quality of research for future health care.

References

  1. Wang, J., Xu, J., Yang, Y., & Xu, H. (2017). GPP based open cellular network towards 5G. China Communications, 14(6), 189-198.
  2. Pacheco-Labrador, J., Perez-Priego, O., El-Madany, T. S., Julitta, T., Rossini, M., Guan, J., … & Migliavacca, M. (2019). Multiple-constraint inversion of SCOPE. Evaluating the potential of GPP and SIF for the retrieval of plant functional traits. Remote Sensing of Environment, 234, 111362.
  3. Hudson, D. M., Werther, R., Weis, M., Wu, J. J., & Eyre, D. R. (2014). Evolutionary origins of C-terminal (GPP) n 3-hydroxyproline formation in vertebrate tendon collagen. PloS one, 9(4), e93467.